Status:
COMPLETED
Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy
Lead Sponsor:
Cosmo Technologies Ltd
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Evaluation of the intraepithelial neoplasia detection rate in patients with long standing ulcerative colitis undergoing mucosal staining with oral methylene blue MMX tablets prior to colonoscopy.
Eligibility Criteria
Inclusion
- endoscopically verified UC signed written informed consent
Exclusion
- Known or suspected GI obstruction or perforation Liver or renal impairment, malignancy, pregnancy or lactation, suppressed PT.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01520324
Start Date
January 1 2012
End Date
July 1 2012
Last Update
February 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Research & Care of Intestinal Diseases
Rozzano, Italy, 20089